Edesa Biotech SMA 200
Was ist das SMA 200 von Edesa Biotech?
SMA 200 von Edesa Biotech, Inc. ist $5 -3.60%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Edesa Biotech
Was macht Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Unternehmen mit sma 200 ähnlich Edesa Biotech
- Wins Finance hat SMA 200 von $5 +68.19%
- Empee Distilleries hat SMA 200 von ₨5 +0.00%
- Silver Heritage hat SMA 200 von AUD$5 -45,100.00%
- Renrui Human Resources Tech hat SMA 200 von $5 +7.75%
- BGC Partners Inc hat SMA 200 von $5 -2.14%
- Stockland Stapled Securities hat SMA 200 von AUD$5 +13.63%
- Edesa Biotech hat SMA 200 von $5 -3.60%
- Actia hat SMA 200 von €5 -12.13%
- Swasti Vinayaka Art and Heritage hat SMA 200 von ₨5 +8.58%
- Sumitomo Mitsui Trust hat SMA 200 von $5 +9.28%
- Kolibri Global hat SMA 200 von CAD$5 -12.61%
- Derichebourg SA hat SMA 200 von €5 +9.57%
- Antevenio, S.A hat SMA 200 von €5 -18.85%